First Turn Management
First Turn Management reported 38 stocks worth $753M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ELVN (5.8%), GH (5.2%) and ABVX (5.1%). Compared with Q2 2026, the fund opened new positions in GH, CRL and RGEN, added to ELVN, INBX and NAMS, trimmed ABVX, ROIV and UTHR and sold out of MIRM, SRRK and ORKA.
Latest filing: what First Turn Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() ELVN Enliven Therapeutics Inc | $43.9M | 5.8% | 959K | +4,340 (+0%) | 7 of 8 | |
| 2 | ![]() GH Guardant Health Inc | $39.1M | 5.2% | 219K | New position | 4 of 8 | |
| 3 | ![]() ABVX Abivax SA | $38.1M | 5.1% | 385K | −105K (−21%) | 5 of 8 | |
| 4 | ![]() ROIV Roivant Sciences Ltd | $36M | 4.8% | 986K | −345K (−26%) | 5 of 8 | |
| 5 | ![]() UTHR United Therapeutics Corp Del | $32.5M | 4.3% | 60K | −25K (−29%) | 5 of 8 | |
| 6 | ![]() VRDN Viridian Therapeutics Inc | $31.4M | 4.2% | 1.5M | −145K (−9%) | 4 of 8 | |
| 7 | ![]() AXSM Axsome Therapeutics Inc | $29.9M | 4.0% | 162K | −56K (−26%) | 8 of 8 | |
| 8 | ![]() INSM Insmed Inc | $28M | 3.7% | 246K | −18K (−7%) | 8 of 8 | |
| 9 | ![]() CELC Celcuity Inc | $26.2M | 3.5% | 329K | No change | 3 of 8 | |
| 10 | ![]() CRL Charles Riv Labs Intl Inc | $25.6M | 3.4% | 87K | New position | 1 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() MIRM Mirum Pharmaceuticals Inc | $25.5M | 218K |
APOGEE THERAPEUTICS INC | $18.4M | 139K |
![]() SRRK Scholar Rock Hldg Corp | $14.9M | 271K |
![]() ORKA Oruka Therapeutics Inc | $14.8M | 155K |
![]() SION Sionna Therapeutics Inc | $4.9M | 110K |
🔒 Free account: see all 6.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →First Turn Management 13F FAQ
What does First Turn Management own?
First Turn Management reported 38 stocks worth $753M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ELVN (5.8%), GH (5.2%) and ABVX (5.1%). The table above lists every position in the filing (the top 10 without an account).
What did First Turn Management buy and sell in Q3 2026?
Compared with Q2 2026: 13 new positions, 5 added to, 19 trimmed and 6 sold out. New positions include GH, CRL and RGEN. It sold all of MIRM, SRRK and ORKA.
When will First Turn Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is First Turn Management's portfolio worth?
The Q3 2026 filing reports $753M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.























